|
|
Eli Lilly & Co CDR
TSX •
Healthcare •
Drug Manufacturers - General •
Quote as of 10/30/2026
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeTSX
Market Capitalization1,649,368 mln
Float32,627 mln
Earnings Date10/29/2026
Key Fundamentals
EPS1.09
P/E46.34
ROE88.57
ROIC31.27
ROA21.74
Interest Cover360
EBITDA, mln51,422
EV / EBITDA35.71
EV / EBIT37.94
Revenue, mln120,018
EV / Revenue15.31
Quote Details
Last
50.51
Change
1.62 (3.31%)
Open
50.27
Volume
170,782
Turnover
8,626,199
Average Volume
111,307
Financial Ratios
Pre-Tax Profit Margin40
Leverage Ratio3.68
Current Ratio1.39
Price / Book33.13
Price / Tangible Book107
Price / Cash Flow41.26
Price / Free Cash Flow64.57
Debt / Equity1.23
Price / Sales14.84
PEG Ratio1.54
Financial Strength
Altman Z-Score9.3
Piotroski F-Score
6
/ 9
Beneish M-Score-2.07
Price to Intrinsic Value8.88
Price to Lynch Fair Value1.51
Price to Graham Number13.47
Shiller PE Ratio140
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
11.11% |
99
/ 100
 |
| 1 Month |
21.95% |
98
/ 100
|
| 2 Months |
18.99% |
92
/ 100
 |
| 6 Months |
50.35% |
98
/ 100
|
|
| |
